Century Therapeutics, Inc.

IPSCReported to SECin USCIK 0001850119Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 9. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 9
Form 4 lines at Century Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Pfeiffenberger BrentPresident and CEOAdministrative$26,86913,850 sharesSep 15, 2026Pfeiffenberger BrentPresident and CEO$26,869Admin · Sep 15Administrative13,850Sep 15, 2026
Russotti GregorySee RemarksOpen-market sell$4,9932,587 sharesSep 15, 2026Russotti GregorySee Remarks$4,993Sell · Sep 15Open-market sell2,587Sep 15, 2026
Carr DouglasSVP Finance & OperationsOpen-market sell$3,2001,658 sharesSep 15, 2026Carr DouglasSVP Finance & Operations$3,200Sell · Sep 15Open-market sell1,658Sep 15, 2026
Truitt Joseph—Awardnothing paid148,000 sharesSep 10, 2026Truitt Josephnothing paidAward · Sep 10Award148,000Sep 10, 2026
Pfeiffenberger BrentPresident and CEOAdministrative$977463 sharesSep 9, 2026Pfeiffenberger BrentPresident and CEO$977Admin · Sep 9Administrative463Sep 9, 2026